← Eichor
Study identifier: NCT07184476 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Assessment of Microvascular Circulation in the Pediatric Cardiac Surgery Patient

Condition: Tetrology of Fallot  ·  Sponsor: Boston Children's Hospital

PhaseN/A
Planned participants40
Who can joinAll sexes, 1 Day to 17 Years
Healthy volunteersNo

About this study

The pediatric cardiac surgery patient endures a tremendous number of physiologic alterations during surgery and cardiopulmonary bypass (CPB) that lasts well into the recovery period. Most of the hemodynamic data are assessed and treated with macrovascular assessment tools such as blood pressure and central venous line measures. Studies show there may be an incoherence of macrovascular to microvascular assessment; i.e. a patient with a stable macrovascular status may not be in the state of microvascular stability. The use of a handheld device called Cytocam incident dark-field (IDF) microcirculatory camera (Braedius Medical, Huizen, Netherlands) gives real-time video screening and data feedback to assess the microvasculature in the hemodynamically labile patient.

This description comes directly from the study's public registry record.

Talk to the study team

Sharon Boyle  ·  6173557077  ·  sharon.boyle@cardio.chboston.org

Always discuss trial participation with your own doctor first.

Locations (1)

Boston Children's HospitalBoston, Massachusetts, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07184476